• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Braly departs, Amerigroup acquisition pending

Article

WellPoint has a history of major acquisitions, and the new CEO already has something on the to-do list.

WellPoint has seen significant growth and diversification in the past decade. After Angela Braly’s departure on August 28, it’s clear that the pending acquisition of Amerigroup will be the first order of business for the incoming CEO.

1999: Angela Braly joins RightCHOICE (an Anthem predecessor) as general counsel

2004: Anthem, Inc. and WellPoint Health Networks, Inc. merge to form WellPoint, Inc.

2005: WellPoint acquires Lumenos; merges with WellChoice

2006: Acquisition of QualChoice Health Plan’s Medicaid operations

2007: Acquisition of American Imaging Management; Angela Braly becomes CEO and President in June

2008: Acquisitions of Resolution Health and DeCare Dental.

2009: WellPoint sells NextRx to Express Scripts, Inc.

2011: Acquisition of CareMore Health Group

2012: Acquisition of 1-800 Contacts, Inc.; announces acquisition of Amerigroup; Angela Braly resigns on August 28.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.